|
ZFYVE9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.88789999999717E-06 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
3.987900E-02 |
| Stage1-vs-Stage3 |
7.815800E-02 |
| Stage1-vs-Stage4 |
1.203980E-03 |
| Stage2-vs-Stage3 |
3.718600E-03 |
| Stage2-vs-Stage4 |
2.166500E-04 |
| Stage3-vs-Stage4 |
1.863960E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
2.09039999976568E-07 |
| Normal-vs-Asian |
3.5518255003808E-12 |
| Caucasian-vs-AfricanAmerican |
3.589600E-01 |
| Caucasian-vs-Asian |
9.578600E-01 |
| AfricanAmerican-vs-Asian |
3.856800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.77236045021345E-15 |
| Normal-vs-Female |
1.63458135915562E-12 |
| Male-vs-Female |
7.282200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62725388719309E-12 |
| Normal-vs-Age(81-100Yrs) |
3.79070000000592E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.383600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.920600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.841600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.971200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.835800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.002200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.85550000003843E-06 |
| Classical-VS-Follicular |
7.264300E-03 |
| Classical-VS-Other |
8.327000E-01 |
| Classical-VS-Normal |
1.76481051994415E-12 |
| Tall-VS-Follicular |
2.64849999709327E-08 |
| Tall-VS-Other |
2.833400E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
3.183200E-01 |
| Follicular-VS-Normal |
9.06349995055677E-10 |
| Other-VS-Normal |
5.228600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
3.88578058618805E-15 |
| N0-vs-N1 |
1.566010E-02 |
|
|
